Pretreatment level of CA 19-9 is a prognostic factor in advanced pancreatic cancer treated with chemotherapy

被引：0
|
作者：
Gansl, R. C. [1 ]
Reis, P. T. [1 ]
Tabacof, J. [1 ]
Simon, S. D. [1 ]
Machado, M. C. [1 ]
Borghesi, G. [1 ]
Saad, E. D. [1 ]
机构：
[1] Dendrix, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15637
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15637
引用
收藏
页数：1
相关论文
共 50 条
  • [31] CA 19-9 RELATED TUMOR GROWTH RATE AFTER FIRST LINE CHEMOTHERAPY OF ADVANCED PANCREATIC CANCER
    Giuseppe, Colloca
    Antonella, Venturino
    Zaira, Coccorullo
    Domenico, Guarneri
    Graziano, Caltabiano
    Gianfranco, Addamo
    Riccardo, Ratti
    Lazzaro, Repetto
    ANNALS OF ONCOLOGY, 2014, 25 : 79 - 79
  • [32] Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9
    Lundin, J
    Roberts, PJ
    Kuusela, P
    Haglund, C
    ANTICANCER RESEARCH, 1995, 15 (5B) : 2181 - 2186
  • [33] The Effect on Prognosis of Postoperative CA 19-9 Level in Patients With Pancreatic Cancer
    Kilickap, Saadettin
    Arslan, Cagatay
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 320 - 320
  • [34] Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer
    Jo, Jae-Cheol
    Ryu, Min-Hee
    Koo, Dong-Hoe
    Ryoo, Baek-Yeol
    Kim, Hwa Jung
    Kim, Tae Won
    Choi, Kee Don
    Lee, Gin Hyug
    Jung, Hwoon-Yong
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kim, Jin-Ho
    Kang, Yoon-Koo
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) : 324 - 330
  • [35] Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer and chronic renal failure: Second highest level of CA 19-9 in the literature
    Aytekin, Aydin
    Sahin, Suleyman
    Hacioglu, Muhammet Bekir
    Karatas, Fatih
    Ince, Menre
    JOURNAL OF BUON, 2015, 20 (04): : 1169 - 1170
  • [36] CA 19-9: Not a magic marker for pancreatic cancer
    Daram, Sumanth R.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (03) : 205 - 205
  • [37] Exploiting the relevance of CA 19-9 in pancreatic cancer
    Salleh, Syaza
    Thyagarajan, Anita
    Sahu, Ravi P.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
  • [38] Is CA 19-9 useful in the management of pancreatic cancer?
    Balzano, Gianpaolo
    Di Carlo, Valerio
    LANCET ONCOLOGY, 2008, 9 (02): : 89 - 91
  • [39] CA 19-9 and Lewis Antigens in Pancreatic Cancer
    Atkins, Carl D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2572 - 2573
  • [40] Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survival
    Heger, Ulrike
    Sun, Huihui
    Hinz, Ulf
    Klaiber, Ulla
    Tanaka, Masayuki
    Liu, Bing
    Sachsenmaier, Milena
    Springfeld, Christoph
    Michalski, Christoph W.
    Buechler, Markus W.
    Hackert, Thilo
    HPB, 2020, 22 (02) : 224 - 232
12345